Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Indiana › NPI 1356334510
Clinic

Indiana Regional Medical Center

Indiana Regional Medical Center was paid $10.63M by Medicaid between Jan 2018 and Dec 2024, across 278 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.

33Billing provider infoINDIANA REGIONAL MEDICAL CENTER
INDIANA, PA 15701
33aNPI1356334510assigned 08/23/2005
33bProvider typeClinic/Center
28Total paid$10.63M
24GClaims305,845
24DCodes billed278
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinic/Center providers in Pennsylvania

Rank by total paid#16 of 176
Median peer was paid$441K
This provider vs. median24×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018665$60K
2019556$40K
202024,198$689K
2021135,889$4.29M
202248,419$1.93M
202353,632$1.94M
2024incomplete42,486$1.68M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 17,581 17,210 $1.70M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 11,138 10,707 $1.55M
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 12% 20,164 18,907 $1.33M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.3% 2,952 2,689 $561K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 5.0% 6,445 6,178 $530K
G0378 Hospital observation service, per hour 4.5% 1,034 509 $478K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3.1% 5,095 4,414 $331K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.1% 5,348 4,491 $329K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3.0% 6,910 6,137 $321K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.7% 6,291 6,184 $286K
X0616 2.5% 1,035 1,008 $264K
80053 Comprehensive metabolic panel 2.2% 24,535 22,894 $236K
266 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.6% 3,940 $168K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.0% 22,098 $108K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.0% 606 $106K
84443 Thyroid stimulating hormone (TSH) <1% 4,421 $86K
80061 Lipid panel <1% 6,020 $78K
X0621 <1% 357 $78K
80050 General health panel <1% 1,372 $68K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,284 $68K
X0620 <1% 257 $67K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 248 $64K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 561 $59K
87428 <1% 2,091 $57K
71045 Radiologic examination, chest; single view <1% 3,813 $53K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 707 $52K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,213 $48K
77067 Screening mammography, bilateral, including computer-aided detection <1% 599 $47K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 484 $46K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,466 $42K
70450 Computed tomography, head or brain; without contrast material <1% 667 $42K
96361 Intravenous infusion, hydration; each additional hour <1% 2,357 $41K
0001A <1% 981 $41K
71046 Radiologic examination, chest; 2 views <1% 1,656 $41K
0002A <1% 978 $40K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,153 $37K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 323 $37K
85027 <1% 5,522 $33K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 327 $30K
84703 <1% 3,372 $29K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,215 $29K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,213 $28K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 684 $28K
96375 Therapeutic injection; each additional sequential IV push <1% 1,395 $27K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 278 $27K
76830 Ultrasound, transvaginal <1% 476 $23K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,210 $22K
84484 <1% 3,039 $20K
78815 Positron emission tomography (PET) for limited area imaging <1% 24 $19K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 243 $19K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,517 $19K
93976 <1% 239 $19K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 599 $19K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 73 $16K
83036 Hemoglobin; glycosylated (A1C) <1% 2,481 $16K
80048 Basic metabolic panel (calcium, ionized) <1% 2,386 $15K
84481 <1% 653 $15K
81001 <1% 5,696 $15K
95811 <1% 26 $14K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 91 $14K
20553 <1% 319 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,155 $14K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 503 $14K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 271 $13K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 224 $12K
77063 Screening digital breast tomosynthesis, bilateral <1% 586 $12K
80306 <1% 1,029 $12K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 215 $12K
86618 <1% 515 $11K
88342 <1% 334 $11K
82607 <1% 909 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 605 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 272 $11K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 712 $10K
82728 <1% 946 $10K
84439 <1% 1,219 $10K
93971 <1% 154 $10K
86780 <1% 615 $9K
72125 Computed tomography, cervical spine; without contrast material <1% 115 $8K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 42 $8K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 47 $8K
0004A <1% 199 $8K
83540 <1% 1,084 $8K
83690 <1% 1,816 $8K
76642 <1% 165 $8K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 295 $7K
76536 <1% 152 $7K
88313 <1% 213 $7K
87340 <1% 499 $7K
88312 <1% 169 $7K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 301 $7K
87186 <1% 871 $6K
73030 <1% 374 $6K
73564 <1% 270 $6K
86038 <1% 415 $6K
73610 <1% 350 $6K
83880 <1% 268 $6K
87077 <1% 868 $6K
82570 <1% 832 $6K
86762 <1% 296 $6K
73630 <1% 456 $6K
59025 Fetal non-stress test <1% 288 $5K
87040 <1% 624 $5K
84153 <1% 227 $5K
80076 <1% 594 $5K
84146 <1% 221 $5K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 97 $5K
95806 <1% 80 $5K
84702 <1% 306 $5K
95886 <1% 132 $5K
85610 <1% 1,997 $5K
76775 <1% 117 $5K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 538 $4K
86900 <1% 568 $4K
82746 <1% 371 $4K
36415 Collection of venous blood by venipuncture <1% 4,106 $4K
85652 <1% 1,515 $4K
86140 <1% 1,416 $4K
81003 <1% 1,597 $4K
82043 <1% 531 $4K
12001 <1% 71 $4K
83735 <1% 772 $4K
86850 <1% 507 $4K
83550 <1% 889 $4K
73130 <1% 323 $4K
86235 <1% 83 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,643 $4K
96523 <1% 232 $4K
76801 <1% 82 $4K
87070 <1% 622 $4K
72110 <1% 161 $4K
86160 <1% 126 $4K
87522 Neg quan hep c or qual rna <1% 93 $4K
85730 <1% 691 $4K
82565 <1% 598 $4K
85379 <1% 449 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 6,306 $3K
72100 <1% 312 $3K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 17 $3K
87075 <1% 374 $3K
93017 <1% 90 $3K
74018 <1% 231 $3K
73562 <1% 161 $3K
80164 <1% 178 $3K
86800 <1% 146 $3K
84145 <1% 211 $3K
83605 <1% 535 $3K
86431 <1% 350 $3K
87210 <1% 425 $3K
94664 <1% 331 $2K
86901 <1% 572 $2K
87807 <1% 191 $2K
90715 <1% 483 $2K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 153 $2K
93970 <1% 29 $2K
73110 <1% 184 $2K
84403 <1% 74 $2K
83001 <1% 110 $2K
96367 <1% 72 $2K
83615 <1% 315 $2K
73502 <1% 102 $2K
86376 <1% 228 $2K
82550 <1% 334 $2K
82784 <1% 93 $2K
71250 <1% 37 $2K
86039 <1% 130 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 99 $2K
84550 <1% 305 $2K
0071A <1% 45 $2K
86706 <1% 122 $2K
87081 <1% 282 $2K
J2704 Injection, propofol, 10 mg <1% 2,960 $1K
84460 <1% 202 $1K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,527 $1K
84450 <1% 201 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 198 $1K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 613 $1K
70551 Magnetic resonance imaging, brain; without contrast material <1% 12 $1K
83970 <1% 44 $1K
J1756 Injection, iron sucrose, 1 mg <1% 246 $1K
85007 <1% 336 $1K
77066 Tomosynthesis, mammo <1% 13 $1K
94060 <1% 38 $1K
83721 <1% 111 $1K
0072A <1% 29 $1K
J3490 Unclassified drugs <1% 2,244 $1K
86200 <1% 78 $1K
84100 <1% 210 $1K
84402 <1% 39 $1K
93271 <1% 16 $1K
80074 <1% 26 $1K
84165 <1% 77 $1K
84156 <1% 253 $935.26
87102 <1% 98 $931.67
72050 <1% 31 $880.47
82950 <1% 133 $863.95
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,586 $859.09
86225 <1% 64 $846.13
82962 <1% 777 $779.60
80178 <1% 108 $754.59
82248 <1% 120 $746.10
80069 <1% 134 $727.79
83002 <1% 40 $691.13
94729 <1% 26 $673.95
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 25 $658.95
86787 <1% 38 $653.01
J1030 Injection, methylprednisolone acetate, 40 mg <1% 416 $650.38
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,876 $650.17
97597 <1% 15 $648.21
81002 <1% 200 $578.07
84520 <1% 129 $574.82
3044F <1% 1,076 $542.56
86705 <1% 40 $507.81
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 14 $462.15
94727 <1% 24 $446.37
73590 <1% 29 $397.15
84681 <1% 12 $395.19
82533 <1% 29 $386.60
80299 <1% 22 $383.28
87046 <1% 42 $374.93
71101 <1% 28 $360.68
86592 <1% 89 $349.50
82670 <1% 16 $324.30
87076 <1% 24 $321.19
73080 <1% 25 $312.99
J1170 Injection, hydromorphone, up to 4 mg <1% 159 $304.37
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 685 $291.84
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 13 $276.55
87045 <1% 41 $252.29
82103 <1% 14 $252.24
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,479 $235.39
82947 <1% 56 $199.89
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,293 $197.35
J2270 Injection, morphine sulfate, up to 10 mg <1% 156 $182.89
81025 <1% 42 $177.60
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,100 $168.89
86708 <1% 12 $168.18
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,096 $161.83
93270 <1% 16 $142.59
72202 <1% 12 $138.60
82390 <1% 12 $131.00
82330 <1% 15 $112.49
76000 <1% 74 $96.60
85046 <1% 15 $89.34
J2060 Injection, lorazepam, 2 mg <1% 360 $88.95
84155 <1% 45 $88.89
73140 <1% 13 $86.40
A6021 Collagen dressing, sterile, size 16 sq. in. or less, each <1% 19 $85.00
36591 <1% 23 $82.15
A6212 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing <1% 34 $80.40
A4606 Oxygen probe for use with oximeter device, replacement <1% 326 $73.92
88304 <1% 30 $61.10
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 48 $59.95
82010 <1% 13 $53.06
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 410 $52.93
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 17 $52.11
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,004 $50.15
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 361 $46.49
J1644 Injection, heparin sodium, per 1000 units <1% 253 $41.66
J3370 Injection, vancomycin hcl, 500 mg <1% 15 $41.17
94760 <1% 119 $38.16
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 846 $36.88
J0690 Injection, cefazolin sodium, 500 mg <1% 274 $35.25
72020 <1% 30 $34.72
3051F <1% 110 $12.36
J7050 Infusion, normal saline solution, 250 cc <1% 81 $11.08
J1650 Injection, enoxaparin sodium, 10 mg <1% 20 $3.04
C9399 Unclassified drugs or biologicals 0% 18 $0.00
3052F 0% 47 $0.00
J0561 Injection, penicillin g benzathine, 100,000 units 0% 16 $0.00
72040 0% 14 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 38 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 12 $0.00
3046F 0% 81 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 115 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 15 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 42 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 34 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialICKOWSKI, MICHAEL (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under ICKOWSKI, MICHAEL

Full network →
ProviderLocationPaid
Eastern Niagara Hospital, INCLockport, NY$5.05M
Eastern Niagara Medical GroupLockport, NY$85K
Indiana Regional Medical CenterIndiana, PA$84K
Eastern Niagara Hospital INCLockport, NY$9K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.